Two Sigma Advisers LP Has $62.29 Million Position in UiPath Inc. (NYSE:PATH)

Two Sigma Advisers LP grew its holdings in shares of UiPath Inc. (NYSE:PATH) by 29.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,901,000 shares of the company’s stock after buying an additional 1,100,800 shares during the quarter. Two Sigma Advisers LP owned approximately 0.89% of UiPath worth $62,292,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of PATH. Vanguard Group Inc. raised its holdings in UiPath by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 46,664,124 shares of the company’s stock worth $593,101,000 after acquiring an additional 576,458 shares in the last quarter. Senvest Management LLC increased its position in shares of UiPath by 29.2% during the 4th quarter. Senvest Management LLC now owns 14,074,783 shares of the company’s stock worth $178,890,000 after purchasing an additional 3,180,300 shares during the last quarter. AQR Capital Management LLC increased its position in shares of UiPath by 45.3% during the 4th quarter. AQR Capital Management LLC now owns 6,646,320 shares of the company’s stock worth $84,209,000 after purchasing an additional 2,072,089 shares during the last quarter. Norges Bank bought a new stake in shares of UiPath during the 4th quarter worth approximately $71,191,000. Finally, Jacobs Levy Equity Management Inc. lifted its stake in UiPath by 35.6% in the fourth quarter. Jacobs Levy Equity Management Inc. now owns 5,459,071 shares of the company’s stock valued at $69,385,000 after acquiring an additional 1,432,569 shares during the last quarter. 62.50% of the stock is currently owned by institutional investors and hedge funds.

UiPath Stock Down 2.6%

PATH stock opened at $12.59 on Tuesday. The firm has a market cap of $6.94 billion, a PE ratio of -78.69 and a beta of 1.01. The business has a 50 day moving average of $11.21 and a 200-day moving average of $12.72. UiPath Inc. has a 12-month low of $9.38 and a 12-month high of $20.51.

Insiders Place Their Bets

In other news, CAO Hitesh Ramani sold 12,500 shares of the firm’s stock in a transaction that occurred on Thursday, April 3rd. The shares were sold at an average price of $10.19, for a total transaction of $127,375.00. Following the completion of the sale, the chief accounting officer now owns 314,891 shares in the company, valued at $3,208,739.29. This trade represents a 3.82% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Ashim Gupta sold 98,795 shares of UiPath stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $12.01, for a total transaction of $1,186,527.95. Following the completion of the sale, the chief financial officer now directly owns 987,322 shares in the company, valued at $11,857,737.22. This trade represents a 9.10% decrease in their position. The disclosure for this sale can be found here. Insiders own 22.37% of the company’s stock.

Analyst Upgrades and Downgrades

PATH has been the subject of a number of research analyst reports. Royal Bank of Canada restated a “sector perform” rating and set a $13.00 price objective on shares of UiPath in a report on Wednesday, March 26th. Bank of America restated an “underperform” rating and issued a $10.00 target price (down from $18.00) on shares of UiPath in a research report on Thursday, March 13th. Wells Fargo & Company dropped their price objective on UiPath from $13.00 to $11.00 and set an “equal weight” rating for the company in a research report on Thursday, March 13th. Canaccord Genuity Group cut their target price on shares of UiPath from $19.00 to $14.00 and set a “buy” rating on the stock in a research report on Thursday, March 13th. Finally, UBS Group reduced their price target on UiPath from $14.00 to $10.00 and set a “sell” rating on the stock in a report on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, UiPath currently has a consensus rating of “Hold” and a consensus price target of $12.72.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.